Trialect

Active

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

National Institutes of Health

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns this can include a pilot/feasibility clinical trial if necessary, improving trial design and rigor.

Deadlines:

Letter of Intent Due Date(s): 30 days prior to the application due date.
Application Due Dates: Oct 25, 2022; Feb 24, 2023; June 26, 2023; Oct 25, 2023; Feb 27, 2024; June 25, 2024; Oct 25, 2024; Feb 25, 2025; June 25, 2025
AIDS Application Due Dates: Jan 7, May 7, Sep 7

PAR-22-174 Expiration Date September 08, 2025

Specialties

Medical

Medical - Clinical Science

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

View Funding Opportunity

Grant

Final Deadline:

Oct 25, 2024

LOI Deadline: 30 days prior to the application due date. Application Due Dates: Oct 25, 2022; Feb 24, 2023; June 26, 2023; Oct 25, 2023; Feb 27, 2024; June 25, 2024; Oct 25, 2024; Feb 25, 2025; June 25, 2025